Aims: Atrial fibrillation (AF) is a frequent comorbidity in heart failure (HF). We analysed factors associated with new-onset atrial fibrillation in patients with heart failure using linked real-world UK data from primary and secondary care, along with findings from genome-wide association studies.

Methods And Results: Among 163 174 participants with a diagnosis of HF (January 1998 to May 2016) from Clinical Practice Research Datalink (CPRD) and Hospital Episodes Statistics (HES), 111 595 participants had no previous history of AF (mean age 76.3 ± 12.6; 50.3% women; 95.8% white ethnicity). Multivariate weighted Cox regression was used to identify predictors for new-onset AF. Linkage disequilibrium score regression was performed to assess the strength of the genetic correlation between AF and identified predictors. During follow-up (median 1.33 years, IQR 0.15-4.18), the incidence rate for AF was 2.8% at 30 days, 9.9% at 1 year, 18.0% at 3 years, and 24.9% at 5 years after HF diagnosis after HF diagnosis. Female sex (HR = 0.79, 95% CI 0.71-0.88), age (HR = 1.04, 95% CI 1.04-1.04), white ethnicity (HR = 1.30, 95% CI 1.06-1.59), social deprivation (HR = 1.20, 95% CI 1.01-1.42), BMI (HR = 1.01, 95% CI 1.00-1.02), gentle physical activity (HR = 0.84, 95% CI 0.72-0.97), hypertension (HR = 1.15, 95% CI 1.03-1.29), chronic kidney disease (HR = 1.15, 95% CI 1.06-1.24), chronic obstructive pulmonary disease (COPD) (HR = 1.10, 95% CI 1.01-1.19) and valvular heart disease (HR = 1.17, 95% CI 1.06-1.29) were associated with new-onset AF. Angiotensin-converting enzyme inhibitors were associated with lower AF incidence (HR = 0.88, 95% CI 0.80-0.96), and the magnitude of effect was dependent on the duration of administration. Linkage disequilibrium score regression showed important genetic correlation between AF and HF (rg = 0.57, P = 2.30 × 10) and reduced, but still significant, overlap between AF and BMI (rg = 0.19, P = 6.18 × 10), systolic and diastolic blood pressure, smoking, and COPD (P values ranging from <10 to <0.05).

Conclusions: Incident AF in the HF population is high, with good genetic correlation for the two conditions. Identified predictors for new-onset AF might be helpful to improve management of HF patients and AF prevention.

Download full-text PDF

Source
http://dx.doi.org/10.1002/ehf2.15264DOI Listing

Publication Analysis

Top Keywords

atrial fibrillation
12
heart failure
12
95%
11
associated new-onset
8
white ethnicity
8
linkage disequilibrium
8
disequilibrium score
8
score regression
8
genetic correlation
8
hr = 115 95%
8

Similar Publications

Aims: Atrial fibrillation (AF) is a frequent comorbidity in heart failure (HF). We analysed factors associated with new-onset atrial fibrillation in patients with heart failure using linked real-world UK data from primary and secondary care, along with findings from genome-wide association studies.

Methods And Results: Among 163 174 participants with a diagnosis of HF (January 1998 to May 2016) from Clinical Practice Research Datalink (CPRD) and Hospital Episodes Statistics (HES), 111 595 participants had no previous history of AF (mean age 76.

View Article and Find Full Text PDF

A 71-Year-Old Man With Gas Accumulation in the Left Atrium.

Chest

March 2025

Department of Intensive Care Medicine, Ningbo No.2 Hospital, Ningbo, Zhejiang, China.

A 71-year-old man with a history of atrial fibrillation presented to the emergency department with sudden unconsciousness after finishing lunch. Just 4 weeks ago, the patient underwent radiofrequency ablation for atrial fibrillation and regularly took rivaroxaban for anticoagulant therapy. According to the medical history, the patient suffered recurrent chest tightness and heartburn after radiofrequency ablation without other discomforts.

View Article and Find Full Text PDF

Background: The aim of this was to develop an atrial fibrillation (AF) risk score using items usually included in Japanese governmental health check-ups.

Methods And Results: We analyzed data from 6,476 Japanese participants registered in the Suita Study. At baseline, the participants were aged ≥30 years and were free from AF.

View Article and Find Full Text PDF

Background: The use of transcatheter aortic valve implantation (TAVI) for severe aortic stenosis is expanding to patients across the entire spectrum of surgical risk. We aimed to perform a meta-analysis comparing TAVI and surgical aortic valve replacement (SAVR) in trials enrolling lower risk patients.

Methods: We conducted a meta-analysis of randomized controlled trials (RCTs) comparing safety and efficacy outcomes between TAVI and SAVR among lower risk patients (mean/median STS score <4).

View Article and Find Full Text PDF

Background: Pulsed-field ablation (PFA) emerges as an innovative nonthermal energy modality for catheter ablation of atrial fibrillation (AF). This study aimed to assess the safety and effectiveness of a novel PFA system that uses a multichannel, circular ablation catheter with adjustable diameters in treating paroxysmal AF.

Methods: This clinical trial (PF-Beat-AF) was a prospective, multicenter, single-arm study.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!